Literature DB >> 15247602

Risk factors for disseminated candidiasis in children with candidemia.

Theoklis E Zaoutis1, H Mollie Greves, Ebbing Lautenbach, Warren B Bilker, Susan E Coffin.   

Abstract

OBJECTIVE: To determine the risk factors for disseminated infection in hospitalized children with candidemia.
METHODS: We performed a nested case-control study within a cohort of hospitalized children with candidemia. The cohort was defined by all patients with positive blood cultures for Candida species in a large, urban, academic, tertiary care children's hospital from 1998 to 2001. Cases were patients with clinical, microbiologic or radiographic evidence of disseminated candidiasis. Controls were patients with no evidence of disseminated candidiasis.
RESULTS: Among 168 total children with candidemia, the median age was 3.5 years (interquartile range, 0.6-14.3). There were 189 episodes of candidemia. Candida species included:Candida albicans (41%), Candida parapsilosis (24%), Candida glabrata (13%) and Candida tropicalis (9%). The most common underlying diagnoses were oncologic (24%), gastrointestinal (15%) and cardiac (10%) diseases. Eighty-nine patients (53%) were admitted to an intensive care unit, 46 (27%) to a general pediatric or surgical ward and 33 (20%) to the oncology ward. Of the 168 patients with candidemia, 153 were included in the analysis of risk factors for disseminated candidiasis. Of 153 (17%) patients, 26 had evidence of organ dissemination. Organ involvement was most commonly identified in the lung (58%), followed by the liver (23%), kidney (16%), brain (12%), spleen (8%), eye (8%) and heart (8%). Eight of the 26 patients had evidence of dissemination to more than 1 organ. Independent risk factors for disseminated candidiasis were persistently positive blood cultures for Candida (>3 days) with a central venous catheter in place (odds ratio, 3.0; 95% confidence interval, 1.2, 7.8; P = 0.02) and immunosuppression (odds ratio, 2.9; 95% confidence interval, 1.2, 7.0; P = 0.02).
CONCLUSIONS: Prolonged duration of candidemia with a central venous catheter in place and immunosuppression were independent risk factors for disseminated candidiasis in children with candidemia. Furthermore review of the epidemiology of candidemia at our institution revealed a heterogeneous population of children at risk for candidemia and a predominance of non-albicans species as the cause of these infections. Future studies are needed to determine the extent of evaluation needed for detecting dissemination among children with candidemia and to explore interventions for its prevention.

Entities:  

Mesh:

Year:  2004        PMID: 15247602     DOI: 10.1097/01.inf.0000128781.77600.6f

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  35 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.

Authors:  Daniel K Benjamin; Timothy Driscoll; Nita L Seibel; Corina E Gonzalez; Maureen M Roden; Rahki Kilaru; Kay Clark; James A Dowell; Jennifer Schranz; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Authors:  Javier Pemán; Emilia Cantón; María José Linares-Sicilia; Eva María Roselló; Nuria Borrell; María Teresa Ruiz-Pérez-de-Pipaon; Jesús Guinea; Julio García; Aurelio Porras; Ana María García-Tapia; Luisa Pérez-Del-Molino; Anabel Suárez; Julia Alcoba; Inmaculada García-García
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

Review 4.  Treatment principles for Candida and Cryptococcus.

Authors:  Laura C Whitney; Tihana Bicanic
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

5.  Risk factors for candidemia in pediatric intensive care unit patients.

Authors:  Hasan Ağın; Ilker Devrim; Rana Işgüder; Utku Karaarslan; Esra Kanık; Ilker Günay; Miray Kışla; Sultan Aydın; Gamze Gülfidan
Journal:  Indian J Pediatr       Date:  2014-03-14       Impact factor: 1.967

6.  Tackling candidemia in pediatric intensive care units… a global concern!

Authors:  Karthi Nallasamy; Sunit C Singhi
Journal:  Indian J Pediatr       Date:  2014-10-12       Impact factor: 1.967

7.  A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia.

Authors:  A C Pasqualotto; W L Nedel; T S Machado; L C Severo
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

Review 8.  Invasive candidiasis in pediatric intensive care units.

Authors:  Sunit Singhi; Akash Deep
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

9.  Ocular manifestations of candidemia in children.

Authors:  Julie L Fierro; Priya A Prasad; Brian T Fisher; Jeffrey S Gerber; Susan E Coffin; Thomas J Walsh; Theoklis E Zaoutis
Journal:  Pediatr Infect Dis J       Date:  2013-01       Impact factor: 2.129

Review 10.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.